These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 7800899)

  • 1. [The pharmacological prevention of atrial fibrillation after cardioversion].
    López Gil M; Arribas F; Cosío FG
    Rev Esp Cardiol; 1994 Nov; 47(11):715-8. PubMed ID: 7800899
    [No Abstract]   [Full Text] [Related]  

  • 2. Amiodarone versus Sotalol and Propafenone for prevention of immediate recurrence of atrial fibrillation after internal cardioversion: importance of P wave analysis.
    Gorenek B; Cavusoglu Y; Goktekin O; Birdane A; Kudaiberdieva G; Ata N; Unalir A; Timuralp B
    Int J Cardiol; 2006 Jan; 106(2):268-9. PubMed ID: 16321704
    [No Abstract]   [Full Text] [Related]  

  • 3. [Success of pharmacologic cardioversion and electric cardioversion in patients with atrial fibrillation or flutter in a 5-year retrospective study].
    Bugán V; Renker B; Brunclík P; Baraniková D; Augustín E
    Vnitr Lek; 1994 Apr; 40(4):219-22. PubMed ID: 8184582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation. A survey of a Cochrane review].
    Osbak P; Egede R; Jensen GB
    Ugeskr Laeger; 2008 Nov; 170(47):3870-3. PubMed ID: 19014742
    [No Abstract]   [Full Text] [Related]  

  • 5. [Atrial fibrillation--treatment].
    Jung J; Böhm M
    Dtsch Med Wochenschr; 2001 Dec; 126(51-52):1472-5. PubMed ID: 11753741
    [No Abstract]   [Full Text] [Related]  

  • 6. Amiodarone in atrial fibrillation.
    Levy S
    Int J Clin Pract; 1998 Sep; 52(6):429-31. PubMed ID: 9894383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of atrial fibrillation after cardioversion: results of the PAFAC trial.
    Shelton R
    Eur Heart J; 2004 Dec; 25(23):2174; author reply 2174-5. PubMed ID: 15571844
    [No Abstract]   [Full Text] [Related]  

  • 8. Therapy for atrial fibrillation: control of the ventricular response and prevention of recurrence.
    Sopher SM; Camm AJ
    Coron Artery Dis; 1995 Feb; 6(2):106-14. PubMed ID: 7780615
    [No Abstract]   [Full Text] [Related]  

  • 9. [Is cardioversion always needed in atrial fibrillation?].
    Toivonen L
    Duodecim; 2003; 119(3):171-2. PubMed ID: 12650014
    [No Abstract]   [Full Text] [Related]  

  • 10. Can short-term verapamil therapy reduce the recurrence of atrial fibrillation after successful low energy intracardiac cardioversion?
    Zardo F; Antonini-Canterin F; Brieda M; Hrovatin E; Pavan D; Burelli C; Cervesato E; Nicolosi GL
    Ital Heart J; 2001 Jul; 2(7):513-8. PubMed ID: 11501960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrical and pharmacologic cardioversion for atrial fibrillation.
    Kim SS; Knight BP
    Med Clin North Am; 2008 Jan; 92(1):101-20, xi. PubMed ID: 18061000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Relationship between duration of arrhythmia and subsequent preventive effect of disopyramide after cardioversion in patients with symptomatic paroxysmal and persistent atrial fibrillation].
    Komatsu T; Yomogida K; Nakamura S; Suzuki O; Horiuchi D; Kameda K; Tomita H; Abe N; Owada S; Oikawa K; Okumura K
    J Cardiol; 2003 Sep; 42(3):111-7. PubMed ID: 14526660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of oral magnesium, alone or as an adjuvant to sotalol, after cardioversion in patients with persistent atrial fibrillation.
    Frick M; Darpö B; Ostergren J; Rosenqvist M
    Eur Heart J; 2000 Jul; 21(14):1177-85. PubMed ID: 10924301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral amiodarone increases the efficacy of direct-current cardioversion in restoration of sinus rhythm in patients with chronic atrial fibrillation.
    Capucci A; Villani GQ; Aschieri D; Rosi A; Piepoli MF
    Eur Heart J; 2000 Jan; 21(1):66-73. PubMed ID: 10610746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The contribution of inflammatory process in pathogenesis and natural history of atrial fibrillation].
    Zyśko D; Gajek J; Mazurek W
    Pol Merkur Lekarski; 2005 Feb; 18(104):227-8. PubMed ID: 17877137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maintainance of sinus rhythm after electrical cardioversion of persistent atrial fibrillation.
    Burri H
    Eur Heart J; 2002 Apr; 23(7):586; author reply 586. PubMed ID: 11922651
    [No Abstract]   [Full Text] [Related]  

  • 17. Enhancing electrical cardioversion and preventing immediate reinitiation of hemodynamically deleterious atrial fibrillation with class III drug pretreatment.
    Hayashi M; Tanaka K; Kato T; Morita N; Sato N; Yasutake M; Kobayashi Y; Takano T
    J Cardiovasc Electrophysiol; 2005 Jul; 16(7):740-7. PubMed ID: 16050832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrical and pharmacologic cardioversion for atrial fibrillation.
    Kim SS; Knight BP
    Cardiol Clin; 2009 Feb; 27(1):95-107, ix. PubMed ID: 19111767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Internal cardioversion in chronic atrial fibrillation].
    Mendoza González C; Iturralde Torres P; Guevara Valdivia ME; Nava Townsend S; Rodríguez Chávez L; Rodríguez Briones I
    Arch Cardiol Mex; 2002; 72(2):138-44. PubMed ID: 12148333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of oral sotalol administration before electrical cardioversion of persistent atrial fibrillation.
    Veloso HH
    Eur Heart J; 2001 Aug; 22(16):1512-4. PubMed ID: 11482926
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.